- Home
- GEHC vs EQR Comparison
GEHC vs EQR Comparison
Compare GEHC & EQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEHC
- EQR
- Stock Information
- Founded
- GEHC 1892
- EQR 1993
- Country
- GEHC United States
- EQR United States
- Employees
- GEHC N/A
- EQR N/A
- Industry
- GEHC Computer Software: Prepackaged Software
- EQR Real Estate Investment Trusts
- Sector
- GEHC Technology
- EQR Real Estate
- Exchange
- GEHC Nasdaq
- EQR Nasdaq
- Market Cap
- GEHC 28.1B
- EQR 27.2B
- IPO Year
- GEHC N/A
- EQR 1993
- Fundamental
- Price
- GEHC $62.37
- EQR $68.24
- Analyst Decision
- GEHC Buy
- EQR Buy
- Analyst Count
- GEHC 11
- EQR 16
- Target Price
- GEHC $97.73
- EQR $78.00
- AVG Volume (30 Days)
- GEHC 5.9M
- EQR 2.2M
- Earning Date
- GEHC 04-30-2025
- EQR 04-29-2025
- Dividend Yield
- GEHC 0.22%
- EQR 4.07%
- EPS Growth
- GEHC 43.17
- EQR 23.65
- EPS
- GEHC 4.34
- EQR 2.72
- Revenue
- GEHC $19,672,000,000.00
- EQR $2,980,108,000.00
- Revenue This Year
- GEHC $3.79
- EQR $6.07
- Revenue Next Year
- GEHC $4.73
- EQR $4.37
- P/E Ratio
- GEHC $14.37
- EQR $25.11
- Revenue Growth
- GEHC 0.61
- EQR 3.69
- 52 Week Low
- GEHC $57.65
- EQR $59.41
- 52 Week High
- GEHC $94.80
- EQR $78.83
- Technical
- Relative Strength Index (RSI)
- GEHC 31.41
- EQR 50.26
- Support Level
- GEHC $60.70
- EQR $62.27
- Resistance Level
- GEHC $64.80
- EQR $67.47
- Average True Range (ATR)
- GEHC 3.61
- EQR 2.98
- MACD
- GEHC -0.45
- EQR 0.16
- Stochastic Oscillator
- GEHC 20.21
- EQR 69.58
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
About EQR Equity Residential of Beneficial Interest
Equity Residential owns a portfolio of 311 apartment communities with around 84,000 units and is developing two additional properties with 655 units. The company focuses on owning large, high-quality properties in the urban and suburban submarkets of Southern California, San Francisco, Washington, D.C., New York, Seattle, and Boston.